Huons Co Ltd
KOSDAQ:243070
Operating Margin
Huons Co Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| KR |
H
|
Huons Co Ltd
KOSDAQ:243070
|
333.6B KRW |
7%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
676.4B USD |
40%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
3%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
367.9B USD |
26%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK |
48%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
206.7B CHF |
33%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
181.7B CHF |
33%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
161.8B GBP |
24%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
195.2B USD |
34%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
11%
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
132.6B USD |
27%
|
Huons Co Ltd
Glance View
Huons Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2016-06-03.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Huons Co Ltd's most recent financial statements, the company has Operating Margin of 6.7%.
You don't have any saved screeners yet